Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K. Cunningham, Karin Nielsen‐Saines, Charlotte Perlowski et al.|The Journal of Infectious Diseases|2019Cited by 62
Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their InfantsPatricia M. Flynn, Mark Mirochnick, David E. Shapiro et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 57
Tenofovir Treatment Duration Predicts Proteinuria in a Multiethnic United States Cohort of Children and Adolescents With Perinatal HIV-1 InfectionMurli Purswani, Russell B. Van Dyke, Kunjal Patel et al.|The Pediatric Infectious Disease Journal|2012Cited by 47
Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV InfectionMurli Purswani, Kunjal Patel, Cheryl A. Winkler et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 32
Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral TherapyRisa M. Hoffman, Thomas V. Jones, Sean S. Brummel et al.|Clinical Infectious Diseases|2018Cited by 22